(2022). Recording of patients' mental health and quality of life-related outcomes in primary care: a cross-sectional study in the UK. Bmj Open, 12, e066949. http://doi.org/10.1136/bmjopen-2022-066949
. Primary health care
(2022). Burden and treatment of chronic obstructive pulmonary disease among people using illicit opioids: matched cohort study in England. Bmj Med, 1, e000215. http://doi.org/10.1136/bmjmed-2022-000215
. (2022). Are major lower extremity amputations well recorded in primary care electronic health records?: Insights from primary care electronic health records in England. Prim Health Care Res Dev, 23, e77. http://doi.org/10.1017/s1463423622000718
. (2022). Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case-control studies. Br J Gen Pract, 72, e834-e841. http://doi.org/10.3399/bjgp.2022.0137
. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. Bmj Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243
. (2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis, 17, 2417-2429. http://doi.org/10.2147/copd.s370540
. (2022). Liver blood marker testing in UK primary care: a UK wide cohort study, 2004-2016. Bmj Open, 12, e058967. http://doi.org/10.1136/bmjopen-2021-058967
. (2022). Association between continuity of primary care and both prescribing and adherence of common cardiovascular medications: a cohort study among patients in England. Bmj Open, 12, e063282. http://doi.org/10.1136/bmjopen-2022-063282
. (2021). Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease. Diabetes Obes Metab, 23, 2207-2214. http://doi.org/10.1111/dom.14437
. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781-1795. http://doi.org/10.2147/copd.s365480
.